Cubist Systematic Strategies, LLC Lantheus Holdings, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$77.7 - $123.62 $745,920 - $1.19 Million	9,600 Added 84.96%	20,900 $2.29 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $582,813 - $822,195	-9,900 Reduced 46.7%	11,300 $907,000
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $45,963 - $61,434	900 Added 4.43%	21,200 $1.32 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $411,440 - $576,386	7,400 Added 57.36%	20,300 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $247,107 - $372,075	4,100 Added 46.59%	12,900 $896,000
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $725,208 - $876,920	8,800 New	8,800 $738,000
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $2.05 Million - $3.27 Million	-42,100 Reduced 61.46%	26,400 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $1.92 Million - $2.7 Million	31,300 Added 84.14%	68,500 $4.82 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $2.07 Million - $2.7 Million	37,200 New	37,200 $2.46 Million

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.22B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.